![CellVax](https://storage.googleapis.com/dealroom-images-production/47/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDI0LzA0LzA4L2U3ZmU0NWI5MTNjMGZmMzM4MDI1YWQzOTliZmQ3YjUx.png)
CellVax
VerifiedCellvax | Preclinical CRO | Expertise in Oncology and Osteoarthritis.
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 20 % | (26 %) | (83 %) | 413 % | 33 % | - | 80 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 39 % | 38 % | (588 %) | 40 % | - | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 39 % | 64 % | (451 %) | 47 % | - | - | - |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
investor | $0.0 | round | |
€260k | Grant | ||
Total Funding | 000k |
Related Content
Recent News about CellVax
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.